Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Income Statement [Abstract]    
Revenue
Expenses:    
Research and development 5,420,159 4,739,445
General and administrative 4,418,217 2,764,089
Loss from operations (9,838,376) (7,503,534)
Other income, net 82,387 114,402
Interest expense (992)
Foreign currency exchange loss, net (3,503) (171,914)
Realized loss on sale of securities, net (12,134)
Loss before income taxes (9,760,484) (7,573,180)
Provision for income taxes 2,435
Net loss $ (9,760,484) $ (7,575,615)
Basic and diluted net loss per common share $ (0.92) $ (1.37)
Weighted average shares used in computing basic and diluted net loss per common share 10,648,540 5,519,436